Navigation Links
Week One of All Things Medical Auction Event Starts Monday, March 11, 2013 Conducted by IpAuctions™, Inc.
Date:3/11/2013

Reno, NV (PRWEB) March 11, 2013

IpAuctions™, Inc. is proud to conduct the first annual All Things Medical and will be featuring the University of Arkansas to kick off the event. The Board of Trustees of the University of Arkansas is offering the following patents and applications.

Lot#1208 Human Cytoplasmic Polyadenylation Element Binding Protein Patent Portfolio.

Includes 3 US patents. Diagnostic and/or Therapeutic Tool - This discovery relates to the fields of molecular biology and gene cloning. Specifically relating to the identification, cloning, and characterization of the gene encoding human cytoplasmic polyadenylation element binding protein (hCPEB), with sequence-specific RNA binding activity.

Lot#1209 Patent for Diagnosis of Atypical Mycobacterial Infections.

Includes a single US patent. This novel method amplifies the rDNA of eleven different MOTT species in a single test and does not amplify M. tuberculosis DNA. This test can be applied directly on patient samples, both fresh and formalin-fixed, which greatly decreases the turnaround time.

Lot# 1210 Medical Patent For Method of Diagnosing Heart Disease.

Includes a single US patent. This invention integrates and refines a battery of sensitive and specific tests based on multi-fractal analysis and applies them to digitized EKG data to generate diagnostic/prognostic information. Useful results from these tests can be made available in 15 minutes or less (multi-fractal alpha – MFalpha) to several hours (MF Holder, or the related MF Cascade Coefficient, MFCC).

Lot#1211 Ovarian Cancer Diagnosis Portfolio.

Includes patents and patent applications in the US, Canada, Australia, European and WIPO. Now the University of Arkansas Biochemistry and Molecular Biology department has developed this ‘marker’, ready for further development and trials. The disclosed nucleic acid primer sets, used in combination with quantitative amplification (PCR) of tissue cDNA, can indicate the presence of specific proteases in a tissue sample. The detected proteases are themselves specifically over-expressed in certain cancers, and the presence of their genetic precursors may serve for early detection of associated ovarian and other malignancies, and for the design of interactive therapies for cancer treatment.

Auctions open at Noon PST.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10513353.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. IpAuctions™, Inc. "All Things Medical" Auction event is opening March, 2013.
2. Roche NimbleGen and BGI Develop Advanced MHC Region Capture Technology for Human Disease and Biomedical Research
3. DiaTech Life Sciences Announces Medical Advisory Board
4. Van Andel Institute Partners with UNCF to Recruit Students to Biomedical Research Careers
5. Breaking Study: ICU Medicals Tego® Needlefree Connector Proves More Cost Effective Than Traditional Central Venous Catheter Locks
6. China Sky One Medical to Jointly Launch Adult Stem Cell Research Enterprise
7. Varian Medical Systems Schedules First Quarter FY2012 News Release and Conference Call
8. HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data
9. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
10. Live Press Briefing on Findings of Biomedical Industry CEO Survey
11. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , June 27, 2016  Sequenom, Inc. (NASDAQ: ... enabling healthier lives through the development of innovative products ... the United States denied its ... the claims of Sequenom,s U.S. Patent No. 6,258,540 (",540 ... criteria established by the Supreme Court,s Mayo Collaborative Services ...
(Date:6/27/2016)... -- Liquid Biotech USA , Inc. ... Research Agreement with The University of Pennsylvania ("PENN") ... patients.  The funding will be used to assess ... outcomes in cancer patients undergoing a variety of ... to support the design of a therapeutic, decision-making ...
(Date:6/24/2016)... ... 24, 2016 , ... Researchers at the Universita Politecnica delle Marche in Ancona ... or pleural mesothelioma. Their findings are the subject of a new article on the ... are signposts in the blood, lung fluid or tissue of mesothelioma patients that can ...
(Date:6/23/2016)... Md. , June 23, 2016 A person ... from the crime scene to track the criminal down. ... the U.S. Food and Drug Administration (FDA) uses DNA evidence ... Sound far-fetched? It,s not. The FDA ... sequencing to support investigations of foodborne illnesses. Put as simply ...
Breaking Biology Technology:
(Date:5/16/2016)... --  EyeLock LLC , a market leader of iris-based ... IoT Center of Excellence in Austin, Texas ... embedded iris biometric applications. EyeLock,s iris authentication ... with unmatched biometric accuracy, making it the most proven ... platform uses video technology to deliver a fast and ...
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/15/2016)... , April 15, 2016 ... "Global Gait Biometrics Market 2016-2020,"  report to their ... ) , ,The global gait biometrics market ... 13.98% during the period 2016-2020. Gait ... which can be used to compute factors that ...
Breaking Biology News(10 mins):